Our study sought to explore the actual and potential roles of patients, physicians, and pharmacists, as well as their shared challenges and opportunities, in improving the safety of medication use during pregnancy. We conducted virtual focus groups with 48 women and in-depth interviews with nine physicians and five pharmacists. Qualitative analysis revealed that all three groups of participants reported "playing it safe," the need for an engaged patient making informed decisions, challenges surrounding communication about pregnancy status, and a lack of patient-centric resources. Patients, physicians, and pharmacists are highly motivated to protect developing babies from potential harms of medication use during pregnancy while maintaining the patient's health. Strategic messaging could maximize the effectiveness of these interactions by helping physicians discuss the benefits and risks of medication use during pregnancy, pharmacists screen for pregnancy and counsel on medication safety, and patients using medications to share pregnancy intentions with their providers pre-pregnancy.
Improving safe use of medications during pregnancy
The roles of patients, physicians, and pharmacists
Lynch, M. M., Amoozegar, J. B., McClure, E. M., Squiers, L. B., Broussard, C. S., Lind, J. N., Polen, K. N., Frey, M. T., Gilboa, S. M., & Biermann, J. (2017). Improving safe use of medications during pregnancy: The roles of patients, physicians, and pharmacists. Qualitative Health Research, 27(13), 2071-2080. https://doi.org/10.1177/1049732317732027
Abstract
Publications Info
To contact an RTI author, request a report, or for additional information about publications by our experts, send us your request.
Meet the Experts
View All ExpertsRecent Publications
Article
Multifaceted risk for non-suicidal self-injury only versus suicide attempt in a population-based cohort of adults
Article
Pregnancy rates and clinical outcomes among women living with HIV enrolled in HPTN 052
Article
The influence of mediators on the relationship between antenatal opioid agonist exposure and the severity of neonatal opioid withdrawal syndrome
Article